- Home
- VERV vs CYRX Comparison
VERV vs CYRX Comparison
Compare VERV & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- CYRX
- Stock Information
- Founded
- VERV 2018
- CYRX 1999
- Country
- VERV United States
- CYRX United States
- Employees
- VERV N/A
- CYRX N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- VERV Health Care
- CYRX Health Care
- Exchange
- VERV Nasdaq
- CYRX Nasdaq
- Market Cap
- VERV 382.5M
- CYRX 405.4M
- IPO Year
- VERV 2021
- CYRX N/A
- Fundamental
- Price
- VERV $4.79
- CYRX $6.99
- Analyst Decision
- VERV Strong Buy
- CYRX Buy
- Analyst Count
- VERV 4
- CYRX 7
- Target Price
- VERV $25.75
- CYRX $13.14
- AVG Volume (30 Days)
- VERV 1.4M
- CYRX 408.6K
- Earning Date
- VERV 11-05-2024
- CYRX 11-07-2024
- Dividend Yield
- VERV N/A
- CYRX N/A
- EPS Growth
- VERV N/A
- CYRX N/A
- EPS
- VERV N/A
- CYRX N/A
- Revenue
- VERV $24,396,000.00
- CYRX $226,113,000.00
- Revenue This Year
- VERV $84.66
- CYRX $0.34
- Revenue Next Year
- VERV N/A
- CYRX $8.47
- P/E Ratio
- VERV N/A
- CYRX N/A
- Revenue Growth
- VERV 219.91
- CYRX N/A
- 52 Week Low
- VERV $4.31
- CYRX $5.32
- 52 Week High
- VERV $19.34
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- VERV 32.80
- CYRX 41.99
- Support Level
- VERV $6.02
- CYRX $7.18
- Resistance Level
- VERV $6.68
- CYRX $8.79
- Average True Range (ATR)
- VERV 0.47
- CYRX 0.62
- MACD
- VERV -0.14
- CYRX 0.00
- Stochastic Oscillator
- VERV 0.25
- CYRX 17.05
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.